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background: Obstructive renal artery stenosis (RAS) can lead to hypertension and progressive chronic kidney disease (CKD). While patients with 
peripheral vascular disease (PVD) suffer from higher rates of cardiovascular complications (5 year mortality of approximately 50%), the rate and 
causes of death in patients with RAS who share similar cardiovascular risk factors are not well defined.
methods: We reviewed a consecutive series of patients who underwent renal stenting at our institution between 1/1/2006 and 12/31/2012. The 
primary outcome was all-cause mortality classified by cause of death. All records were confirmed by death certificate or chart review. The probability 
of death was estimated by the Kaplan-Meier method.
results: The series included 285 patients (mean age was 66.5 ±13.6 years and 58% were male). Follow-up was available for 100% patients. The 
overall mortality rate was 23.7% with a mean survival of 5.8 years (95% CI; 5.5, 6.1). Of the 68 deaths, 40 (58.8%) were cardiovascular (13.2% 
Acute myocardial infarction, 13.2% Stroke, 11.8% sudden death, 10.3% congestive heart failure) while 28 (41.2%) were non-cardiovascular (10.3% 
infectious, 8.8% malignancy, 1.5% CKD) (Figure 1).
conclusions: In RAS patients undergoing renal stenting, the mid to long-term prognosis appears favorable compared with other peripheral 
vascular disease populations. Acute cardiovascular events are the most common cause of death, with very low rates attributable to progressive CKD.
 
